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Lead is a non-biodegradable, non-corrosive heavy metal, 
the toxic nature of which has been recognised for millennia.1  
However, the range of health effects at low exposures has 
been recognised only recently. Lead use escalated from the 
late 1800s, and through its multiplicity of uses has become 
a worldwide environmental pollutant present in air, dust, 
soil and water. The many uses include lead in petrol, paint, 
batteries, candles, crystal glass, cellular telephones, computers, 
television sets, pottery, ammunition, protective clothing, 
fishing and wheel-balancing weights, tobacco,2  and in South 
Africa, traditional medicines.3   Human exposure occurs 
mainly through ingestion and inhalation, and to a small degree 
through dermal absorption. 
Flegal and Smith4 estimated that pre-industrial humans 
had blood lead concentrations as low as 0.016 μg/dl. In 2000, 
an estimated 120 million people around the world had blood 
lead concentrations of between 5 and 10 μg/dl, and about 
the same number had concentrations greater than 10 μg/dl, 
a level associated with considerable health risk. Children are 
particularly vulnerable and 40% of all children had blood lead 
concentrations above 5 μg/dl and 20% had concentrations  
≥ 10 μg/dl, with the great majority (97%) of these living in the 
developing world.1
Multiple health effects have been associated with lead 
exposure including systemic effects such as gastrointestinal 
effects, raised blood pressure, anaemia, nephropathy, effects 
on vitamin D metabolism, decreased growth, immune system, 
nervous system and behavioural/cognitive/IQ effects (and, 
as a result, multiple social effects including increased risk 
of violence and substance abuse), nerve conductive effects, 
hearing loss, developmental and reproductive effects, 
genotoxicity and death from encephalopathy.1  However, the 
strength of the evidence supporting the association of these 
health effects with exposure to lead varies.
Leaded petrol is one of the worst public health offenders. 
In countries still using leaded petrol, 90% of the lead in the 
environment comes from emissions in the form of fine particles 
that are inhaled and absorbed through the lungs.5  In the 1980s 
in South Africa, petrol lead levels were among the highest in 
the world. At that time well over 90% of the blood lead levels 
of Cape Town inner-city first-grade school children exceeded 
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Objectives. To estimate the burden of disease attributable to lead 
exposure in South Africa in 2000.
Design. World Health Organization comparative risk 
assessment (CRA) methodology was followed. Recent 
community studies were used to derive mean blood lead 
concentrations in adults and children in urban and rural areas. 
Population-attributable fractions were calculated and applied 
to revised burden of disease estimates for the relevant disease 
categories for South Africa in the year 2000. Monte Carlo 
simulation-modelling techniques were used for the uncertainty 
analysis.
Setting. South Africa.
Subjects. Children under 5 and adults 30 years and older.
Outcome measures. Cardiovascular mortality and disability-
adjusted life years (DALYs) in adults 30 years and older and 
mild mental disability DALYs in children under 5 years.
Results. Lead exposure was estimated to cause 1 428 deaths 
(95% uncertainty interval 1 086-1 772) or 0.27% (95% 
uncertainty interval: 0.21 - 0.34%) of all deaths in South 
Africa in 2000.  Burden of disease attributed to lead exposure 
was dominated by mild mental disability in young children, 
accounting for 75% of the total 58 939 (95% uncertainty interval 
55 413 - 62 500) attributable DALYs. Cardiovascular disease in 
adults accounted for the remainder of the burden.
Conclusions. Even with the phasing out of leaded petrol, 
exposure to lead from its ongoing addition to paint, para-
occupational exposure and its use in backyard ‘cottage 
industries’ will continue to be an important public health 
hazard in South Africa for decades. Young children, especially 
those from disadvantaged communities, remain particularly 
vulnerable to lead exposure and poisoning. 
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10 μg/dl6 and mean blood lead concentrations ranged from 16 
to 18 μg/dl.7,8  
In an informal settlement in the Durban metropolitan region, 
50% of children had blood lead concentrations above 10 μg/dl, 
while in a rural area located 90 - 120 km from Durban only 2% 
of children had blood lead concentrations above this level.3 
Blood lead levels among Johannesburg children ranged from 
6 to 26 μg/dl, with a mean level of 11.9 μg/dl.9  In the lead 
mining town of Aggeneys in the Northern Cape, and in the 
comparison rural community of Pella about 40 km away, mean 
blood lead levels of young children were higher than would be 
expected in a rural setting (16 μg/dl in Aggeneys and 13 μg/dl 
in Pella).10  
With the progressive lowering of the maximum permissible 
petrol lead level since 1986, and the introduction of unleaded 
petrol in the country in 1996, a decline in blood lead levels has 
been observed. By 2002, when the maximum permissible petrol 
lead concentration equalled 0.4 g/l, and unleaded petrol made 
up around 30% of the petrol market share, blood lead levels in 
Cape Town first-grade inner-city children had fallen, with 10% 
having lead levels of 10 μg/dl or higher.11  While efforts are 
underway to phase out the use of leaded petrol, little attention 
has been devoted to childhood exposure to lead used in paint. 
In a recent study,12  lead-based residential paint was found in 
20% of sampled homes in various suburbs of Johannesburg. 
The present study aimed to estimate the health impact of this 
environmental pollutant by quantifying the burden of disease 
attributed to lead exposure in children under 5 and adults 30 
years and older in South Africa in 2000.
Methods 
Comparative risk assessment (CRA) methodology developed 
by the World Health Organization (WHO)13,14 and applied 
specifically to lead exposure1 was used. Exposure was 
characterised by the population distribution of blood lead 
concentrations. The concentration of lead in blood was chosen 
as the exposure variable because it is an objective physiological 
measure which is directly related to health outcome and 
reflects human exposure closely. As differences in blood lead 
concentrations between males and females are very small, 
exposure data for men and women were combined. 
There were no nationally representative data on blood lead 
levels, and exposure was assessed separately for urban and 
rural areas. Exposure data for primary school children (aged 
5 - 12 years) were pooled from studies carried out at three 
urban sites in Cape Town, Johannesburg and Kimberley.11,15 
For the rural sample,15 occupational exposures or ‘hotspots’ 
(in Aggeneys, a lead mining town where lead levels were 
unusually high) were excluded. Due to data limitations, these 
same blood lead concentrations were used for children under 5 
years and children 5 - 14 years of age (Table I), although health 
effects in children 5 - 14 years of age were not quantified in 
this analysis. For adults, urban exposure data were obtained 
from maternal blood lead levels in a study of pregnant women 
in Durban.16  Blood lead levels in rural adults were assumed 
to be the same as in rural children (Table I). As recent data 
were used, data were not corrected downward to adjust for 
programmes phasing out lead in petrol as was done in the 
global CRA study.1 
Blood lead levels follow a skewed distribution to the right 
that can be modelled with a lognormal distribution.1  In the 
global study, Prüss-Üstün et al.1 compiled geometric means 
with standard deviations (SDs) in order to represent population 
exposures. However, these parameters, based on the natural 
logarithms of the values, do not estimate the parameters (μ and 
σ2) of the lognormal distribution. We calculated estimates of 
μ and σ2  for the lognormal distribution using the method-of-
moments:
Let m and s2 be the mean and variance of a sample of lead 
levels, then μ is estimated as ln(m) - ½ σ2 and the estimate of 
σ2 is ln(s2 + m2) – 2 ln(m) where the function ln(.) is the natural 
logarithm. 
For adults and children separately, the proportion of the 
population at specified blood lead concentrations in the urban 
Table I. Estimates of age-specific mean blood lead levels and standard deviations (μg/dl), South Africa, 2000
         Age groups (yrs)  Data sources
Population  Parameter 0 - 4 5 - 14* 15+ Study site    Year   N
Urban   Mean   7.5   7.5 7.4 Children (5 - 12 years)11,15   2002  429
  SD   3.31   3.31 3.85 in Cape Town   
       Johannesburg   2002  382
       Kimberley   2003  355
       Pregnant women in Durban16   1996  296
       for adults 15+
      
Rural   Mean   5.5   5.5 5.5 Children (5 - 12 years)15   2003    98
        SD   2.33   2.33 2.33
*Children 5 - 14 years not included in the analysis.
SD  = standard deviation.
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and rural populations was then estimated on the basis of the 
lognormal distribution. These were weighted according to 
the urban/rural breakdown based on Census 200117 data to 
provide a national estimate of exposure.  
The outcomes assessed in this study were similar to those in 
the global CRA study1 and included cardiovascular diseases 
(CVDs) from elevated systolic blood pressure (in adults 30 
years and older), and  IQ reduction in children under 5 years. 
A loss of IQ points was considered to be a disease burden 
when resulting in mild intellectual impairment or mild mental 
disability (MMD), which was defined as having an IQ score of 
50 - 69 points.1 
Anaemia and gastrointestinal effects are associated with 
extremely high exposures to lead1 and due to individual 
variation, only 20% of people with blood lead concentrations 
above the thresholds,1,18 were assumed to develop symptoms 
in the global CRA study. These outcomes were not included in 
the local assessment, however, since firstly these conditions do 
not appear in the South African burden of disease list,19 and 
secondly, in the local setting the number of people affected 
at very high concentrations (with the 20% adjustment) is 
negligible. 
Nephropathy and encephalopathy are associated with 
even higher exposures to lead, and these exposures were not 
quantified in the local and global CRA since they occur in 
extreme cases. Other outcomes that are likely to be causal but 
were not quantified because of a lack of sufficient evidence on 
causality included developmental and reproductive system 
effects, and social consequences of IQ loss.1  The health risks 
associated with blood lead concentrations considered in this 
analysis are summarised in Table II. In the absence of scientific 
consensus of the lowest level of population risk, a blood lead 
concentration threshold of 5 μg/dl was used in this analysis for 
the related health risks.1
Following the framework of Prüss-Üstün et al.1 in the 
global assessment, the incidence of MMD resulting from IQ 
reduction attributable to lead exposure was estimated and 
used to calculate lead-induced MMD DALYs in children under 
5 years of age. Based on a meta-analysis of several studies, 
Schwartz20 estimated that a mean loss of 2.57 (standard error 
(SE) 0.41) IQ points was associated with an increase in blood 
lead concentration from 10 to 20 μg/dl. The global CRA 
study consequently assumed a linear relationship of 1.3 IQ 
points lost per 5 μg/dl increase in blood lead, for blood lead 
concentrations between 5 and 20 μg/dl. This linear relationship 
was divided into 3 intervals of 5 μg/dl, and the mean loss of 
IQ points in each interval was assigned to its mean blood lead 
concentration.1 A loss of 3.5 IQ points was assumed for blood 
lead concentrations ≥ 20 μg/dl for a total of 4 IQ loss categories 
(Table III).
In order to estimate the incidence of MMD resulting from IQ 
reduction attributable to lead exposure, it was first necessary 
to estimate the proportion of the child population in IQ 
categories corresponding to lead exposure intervals based 
on the assumption that intelligence in human populations 
approximates a normal distribution21 (Table III). We then 
estimated the number of children affected (also referred to 
as the rate of illness) in each IQ-loss category by applying 
the distribution of blood lead concentrations in the child 
population. The proportion of children under 5 at indicated 
blood lead levels was multiplied by the fraction of children 
within the interval 70+x IQ points, for whom a loss of x points 
results in a final IQ score of < 70 points.1  It was assumed that 
loss of IQ and consequent MMD occurs only once during the 
first year of life and the rate of illness for the age group < 1 
year was divided by 5 in order to estimate incidence rates of 
MMD in children aged < 5 years. 
The standard IQ distribution is based on a population less 
exposed to additional risk factors for IQ loss which may be 
more common than exposure to lead in developing countries. 
Prüss-Üstün et al.1 estimated an adjustment ratio to account for 
the increased risk of mental disability in developing countries 
Table II. Summary of health risks associated with blood lead concentrations considered in this analysis
     Blood lead concentration  
     threshold (μg/dl)
Mediating 
outcome     Children  Adults  Description of relationship
IQ reduction           5     NA  Linear relationship assumed
(children aged 0 - 4 years)       BPb between 5 and 20 μg/dl: loss of
         1.3 IQ points per 5 μg/dl increase in BPb
         BPb above 20 μg/dl: loss of 3.5 IQ points 
Increased systolic blood pressure        NA       5  Linear relationship assumed
(adults aged 30 years and older)      BPb between 5 and 20 μg/dl: increase of 1.25  
         mmHg for males, and 0.8 mmHg for females  
         per 5 μg/dl increase in BPb. 
         BPb above 20 μg/dl: increase of 3.75 mmHg for  
         males, and 2.4 mmHg for females.
Source: Adapted from Prüss-Üstün et al., 2004.1
NA = not applicable; BPb = blood lead concentration.
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that would result from anaemia, meningitis, pertussis, 
hookworm and iodine deficiency.22,23  However, MMD caused 
by protein-energy malnutrition could not be taken into 
account. In this analysis, the estimated incidence rate per 1 
000 children affected by lead-induced MMD was multiplied 
by the adjustment ratio estimated for the WHO African region 
which includes South Africa (AFR-E region adjustment ratio 
2.01)1 to yield a national incidence of MMD of 0.96 per 1 000 for 
children under 5 years of age. 
Following standardised global burden of disease (GBD) 
methodology,24,25 years lived with disability (YLDs) due to 
MMD were calculated using the national incidence, duration 
derived from the disease modelling tool DisMod II,26 and 
the MMD Dutch disability weight of 0.290.27  As loss of IQ 
potentially increases the risk of other diseases and violence-
related injuries,28,29 and mental disability has been associated 
with lower life expectancy,1,30 a relative risk of total mortality 
for mental disability of 2 (double that for the total population) 
was used. The duration of disability was estimated at 42.6 
years for males and 48.4 years for females. MMD YLDs 
in children under 5 years were directly attributed to lead 
exposure. 
The contribution of exposure to lead to CVD burden in 
adults is mediated through increased blood pressure. Hazards 
for increased blood pressure associated with increased blood 
lead concentrations were obtained from a meta-analysis by 
Schwartz31 and a published analysis of data from the second 
National Health and Nutrition Examination Survey (NHANES 
II).1 As in the global CRA study, the relationship was assumed 
to be linear between 5 and 20 μg/dl, with a 1.25 mmHg1,31 
increase in systolic blood pressure for each increase of 5 μg/dl 
in blood lead concentration in men and an increase of  
0.8 mmHg32 for each 5 μg/dl increase in women (Table II).1 
Using the same method used for loss of IQ points, the linear 
increase was converted into 3 equal intervals using the 
midpoints of the intervals with the corresponding increase in 
blood pressure. An increase in blood pressure of 3.75 mmHg 
for males and 2.4 mmHg for females was used for blood lead 
concentrations ≥ 20 μg/dl (Table II) for a total of 4 increased 
systolic blood pressure categories. The number of people 
affected in each category was determined from the distribution 
of blood lead concentrations in the population. 
The burden of cardiovascular disease attributable to lead 
exposure in adults 30 years and older was calculated using the 
population-attributable fraction (PAF) formula below: 
where pi is the rate of illness estimated for the ith blood 
pressure category corresponding to each blood lead interval, 
RRi is the relative risk of disease for exposure level i, and k is 
the total number of exposure levels. The risk values for CVD, 
for the defined increases in systolic blood pressure associated 
with increased blood lead concentrations, were based on risk 
ratios obtained from a collaborative meta-analysis of individual 
participant data from 61 separate prospective studies33 used in 
the high blood pressure assessment.34  PAFs were then applied 
to revised South African burden of disease estimates for deaths, 
years of life lost (YLLs) due to premature mortality, YLDs and 
DALYs19 in 2000 for the CVD categories to calculate attributable 
burden. 
Customised MS Excel spreadsheets to calculate the burden 
attributable to lead exposure were based on templates used in 
the WHO global CRA study (A Prüss-Üstün, WHO – personal 
communication, 2005). Monte Carlo simulation-modelling 
techniques were used to present uncertainty ranges around 
point estimates reflecting the main sources of uncertainty in the 
calculations. The @RISK software version 4.5 for Excel35 was 
used, which allows multiple recalculations of a spreadsheet, 
each time choosing a value from distributions defined for 
input variables. Lognormal distributions of the mean blood 
lead concentration were specified by age and sex. For the 
association of increased blood lead concentrations with loss of 
IQ points, a normal distribution with a mean of 100 and SE of 
1 (i.e. 95% of the simulated means will lie between 98 and 102 
points) was specified for the mean IQ in human populations. 
A normal distribution was also specified around the estimated 
decrease in IQ points associated with a 5 μg/dl increase in 
blood lead concentration, with SE derived from that published 
in the meta-analysis.20 For the association between systolic 
Table III. Proportion of the population with shift in IQ score assuming a normal distribution*
	 	 	 	 											Loss	of	IQ	points	 	 	 	 	 																			%	of	the
Blood	lead	 Mean	BPb	 (loss	of	1.3	IQ	points	per		 	 	 	 	 								population	with
levels	(μg/dl)	 						(μg/dl)	 		5	μg/dl	increase	in	BPb)	 	 IQ	loss	categories	 	 								shift	in	IQ	score	
5 - < 10             7.5                   0.65 = (1.3/2)              70 - 70.65                            0.24
10 - < 15           12.5                         0.65 + 1.3              70 - 71.95                            0.80
15 - < 20           17.5                         1.95 + 1.3              70 - 73.25                            1.45
≥ 20                                    3.50              70 - 73.50                            1.59
Adapted from Prüss-Üstün et al., 2004.1
*Mean IQ score of 100, standard deviation of 15.21
BPb =  blood lead concentration.
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blood pressure and blood lead, a normal distribution was 
specified around the risk estimates31,32 and the SEs of these 
risk estimates based on the 95% confidence interval (CI) of 
0.87 - 1.63.31 For the CVD relative risk input variables a normal 
distribution was specified around the logged point estimate 
and its SE derived from the published 95% CI.33 For each of the 
output variables (namely attributable burden as a percentage of 
total burden in South Africa in 2000), 95% uncertainty intervals 
were calculated bounded by the 2.5th and 97.5th percentiles of 
the 2000 iteration values generated.
Results 
It was estimated that 23 million South Africans had blood lead 
concentrations between 5 and < 10 μg/dl in the year 2000, 
and about 4 million people had blood-lead concentrations 
≥ 10 μg/dl (Table IV). Blood lead concentrations in rural 
populations were lower than those in urban populations. 
Seventy-seven per cent of urban children had blood lead 
concentrations ≥ 5 μg/dl, 18.6% had concentrations ≥ 10 μg/dl, 
and 0.6% had concentrations ≥ 20 μg/dl. About half of rural 
children had blood lead concentrations ≥ 5 μg/dl, only 5% had 
concentration ≥ 10 μg/dl, and effectively no rural children had 
levels ≥ 20 μg/dl.
The number of people whose health is affected by exposure 
to lead, estimated from the fraction of the population having 
blood lead concentrations at which health effects occur, is 
presented in Table V. These rates of illness were used to 
calculate the incidence of MMD in children under 5 and PAFs 
for CVD in adults. The incidence rate of MMD due to lead 
exposure was estimated at 4.82 per 1 000 in children under 
1 and at 0.96 (95% uncertainty interval: 0.56 - 1.41) per 1 000 
in the 0 - 4-year age group (data not presented). Using this 
incidence, an estimated 43 986 DALYs due to MMD were 
causally attributed to lead exposure. Assuming that each cohort 
of children aged 0 - < 1 year is exposed to the same amount of 
lead year after year, the prevalence of MMD attributable to lead 
was estimated at 0.5% in children aged 0 - 4.
CVD PAFs were lower in females due to the weaker 
relationship between systolic blood pressure and blood lead 
concentration in females compared with males (Table VI). 
Overall, an estimated 1 428 deaths (95% uncertainty interval  
1 086 - 1 772) or 0.27% of all deaths in South Africa in 2000 
could be attributed to lead exposure (Table VI).  Attributable 
DALYs were slightly higher, 58 939 (95% uncertainty interval 
55 413 - 62 500), or between 0.34% and 0.39% of all DALYs in 
South Africa in 2000 attributable to lead exposure. The MMD 
burden in children under 5 years accounted for 74.6% of the 
total DALYs attributable to lead exposure, while ischaemic 
heart disease (7.0%), stroke (10.4%), hypertensive disease 
(7.6%) and other CVDs (0.4%) accounted for much smaller 
proportions of the total attributable burden (Fig. 1).
Discussion 
These estimates of attributable burden indicate that although 
lead reduction programmes have been initiated in South 
Africa, these have not yet been fully implemented and as 
such this environmental risk still had a significant impact on 
health in 2000. Large fractions of the local population had 
significantly elevated blood lead concentrations and more 
than half (53%) of the national population (about 23 million) 
had blood lead concentrations between 5 and 10 μg/dl. About 
10% of the population (almost 4 million South Africans) were 
estimated to have blood lead concentrations above 10 μg/dl. 
Rural populations in South Africa were also exposed to lead, 
although to a somewhat lower degree.
It should be noted that significant assumptions were 
necessary to overcome the lack of nationally representative 
exposure data. In urban adults, exposure data were obtained 
from a single community study in females and extrapolated 
to the whole country. Rural adults were assumed to have the 
same mean blood lead concentration as rural children, and 
this may lead to an overestimation of exposure in rural adults 
since adult exposures are usually lower than those in children. 
Nationally representative blood lead surveys are necessary 
in our country in order to improve the accuracy of these 
estimates.
It was estimated that lead exposure resulted in a burden of 
disease of about 44 000 DALYs caused by MMD, and about  
13 700 YLLs and 15 000 DALYs caused by CVD. These 2 
disease outcomes together accounted for between 0.34% and 
0.39% of all DALYs in South Africa in 2000. The burden of 
ischaemic heart disease, stroke, hypertensive disease and other 
CVDs attributable to lead exposure constituted about 1.5% of 
the total CVD burden in South Africa in 2000. 
This estimate of burden attributable to lead exposure is 
probably an underestimate of the true attributable burden 
since only MMD caused by IQ reduction and CVD endpoints 
were considered in this analysis. The burden of gastrointestinal 
symptoms and anaemia caused by lead was not assessed 
since the rate of illness for these related health outcomes 
was negligible. In the global assessment the contribution of 
lead to burden from gastrointestinal effects and anaemia was 
considered small compared with that caused by risk factors 
such as unsafe water, poor sanitation and hygiene, and 
iron deficiency. Several additional related health outcomes 
such as increased delinquent behaviour and its impact on 
injuries could not be quantified in this assessment due to 
insufficient evidence. In addition, lack of information on the 
health impact of low lead levels, the exclusion of data from 
studies carried out at ‘hot spots’ with high exposure as well 
as other conservative assumptions listed in this study have 
all contributed to a possible underestimation of the burden of 
disease attributable to lead exposure. 
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Mean blood lead concentrations in the South African 
population were slightly lower than the AFR-E estimates in 
both children and adults for 2 main reasons. Firstly, more 
recent and locally representative data were used in this 
analysis. Secondly, the method used in the estimation of 
parameters for the distribution of blood lead concentrations 
in the global assessment1 yielded inflated estimates of the 
SDs. The proportion of children affected and the rate of illness 
at the lower blood lead concentrations in this study was 
several-fold higher than the rate estimated for AFR-E, while 
that at high blood lead concentrations (≥ 20 μg/dl) was much 
lower. The global assessment method of parameter estimation 
underestimates the percentage of people at lower blood lead 
concentrations but overestimates the proportion at risk at 
higher blood lead concentrations. 
Nevertheless, the estimated prevalence of MMD attributable 
to lead exposure (0.5%) was comparable to that estimated for 
the AFR-E region.1 It has been estimated that 40% of MMD is 
of genetic origin, 20% is caused by environmental factors and 
40% is of unknown aetiology36 and in developing countries the 
contribution of lead to the total incidence of MMD is thought 
to be as high as 15 - 20%.1  The high prevalence of MMD in 
Table IV. Proportion of the urban and rural population at indicated blood lead levels, South Africa, 2000
	 	 	 	 	 	 	 	 	 														Age	group	(yrs)
Blood	lead	concentrations	 	 Population	 	 	 								0	-	4		 						5	-	14	 	 										15+
BPb 5 - < 10 μg/dl   Urban (%)           58.7          58.7            58.0
    Rural (%)            46.6          46.6            46.6
    National (%)           53.1          53.1            52.7
    Population affected (N)  2 805 238  4 895 283  15 526 112
    
BPb 10 - < 15 μg/dl   Urban (%)           15.4          15.4            13.1
    Rural (%)              4.3            4.3              4.3
    National (%)           10.3          10.3              9.0
    Population affected (N)     542 897    947 383    2 656 284
    
BPb 15 - < 20 μg/dl   Urban (%)             2.6            2.6              2.0
    Rural (%)              0.3            0.3              0.3
    National (%)             1.6            1.6              1.2
    Population affected (N)       82 816     144 518       363 523
    
BPb ≥ 20 μg/dl   Urban (%)            0.60          0.60            0.40
    Rural (%)             0.00          0.00            0.00
    National (%)            0.32          0.32            0.23
    Population affected (N)       16 789      29 297        66 697
BPb = blood lead concentration.
Table V. Number of people affected (per 1 000 population) by loss of IQ points and increased systolic blood pressure with 
increased blood lead concentrations caused by exposure to lead, South Africa, 2000
Mediating outcome          Rate per 1 000 population
IQ loss categories          
Children < 1 years  
IQ (1) – loss of 0.65 points (5 - < 10 μg/dl BPb)                         531.0*
IQ (2) – loss of 1.95 points (10 - < 15 μg/dl BPb)                         102.8*
IQ (3) – loss of 3.25 points (15 - < 20 μg/dl BPb)                           15.7*
IQ (4) – loss of 3.5 points (≥ 20 μg/dl BPb)                             3.2*
Increased systolic blood pressure categories 
Males (≥ 15 yrs)†    Females (≥ 15 yrs)† 
BP (1) + 0.625 mmHg (5 - < 10 μg/dl BPb) BP (1) + 0.4 mmHg (5 - < 10 μg/dl BPb)                      526.9
BP (2) + 1.875 mmHg (10 - < 15 μg/dl BPb) BP (2) + 1.2 mmHg (10 - < 15 μg/dl BPb)                       90.1
BP (3) + 3.125 mmHg (15 - < 20 μg/dl BPb) BP (3) + 2.0 mmHg (15 - < 20 μg/dl BPb)                       12.3
BP (4) + 3.75 mmHg (≥ 20 μg/dl BPb)  BP (4) + 2.4 mmHg (≥ 20 μg/dl BPb)                          2.3
*Values presented were those estimated for the age group less than 1 year. These were divided by a factor of 5 (as the age group 0 - 4 years includes five 1-year cohorts of children) in 
order to estimate incidence rates of MMD in children aged < 5 years.
†Same rates of illness assumed for adults 30+.
BP = blood pressure (systolic); BPb = blood lead concentration. 
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developing countries highlights the role 
of avoidable and preventable exposure 
to harmful environmental factors such 
as lead. 
In addition to the burden of disease, 
lead exposure also has an important 
socio-economic component. In the 
USA it has been estimated that US$900 
million per year in remedial education 
costs could be prevented by lead-
reduction programmes,37 and for every 
IQ point raised in the population, 
worker productivity is raised resulting 
in an economic benefit of almost 
US$320 million for each year’s cohort 
of children.38  Social factors assume 
importance in predisposing children 
to lead in the environment.7 Exposure 
to lead tends to be higher in the 
lower socio-economic groups of the 
population.39  Poorer populations are 
forced to live in areas that are more 
exposed to industrial pollution, closer 
to busy roads and highways or in 
degraded housing with old, flaking 
lead-based paint and lead water pipes, 
which has serious implications for 
inequalities in health.
Albeit in a piecemeal fashion, 
there have been some significant 
developments in South Africa in recent 
years that hold considerable promise of 
reducing children’s exposure to lead. In 
2006 the use of leaded petrol was phased 
out. In addition, following the discovery 
by Medical Research Council researchers 
that lead is still being added to certain 
paints in South Africa in some instances 
at extremely high concentrations, 
legislation is currently being drafted to 
prohibit this practice.40  A lead hazard 
awareness initiative was also launched 
by the Department of Health and the 
MRC. These steps are likely to lead to 
significant reductions in lead exposure 
among South African children.
Conclusion and 
recommendations
The total disease burden attributable 
to lead in South Africa is, in principle, 
preventable through the implementation 
of a comprehensive, intersectoral lead-
poisoning prevention programme. The 
outstanding lead-poisoning prevention 
agenda in South Africa includes research 
Fig. 1. Burden of disease attributable to lead exposure, South Africa, 2000.
Ta
bl
e 
V
I.
 B
ur
de
n 
at
tr
ib
ut
ab
le
 to
 le
ad
 e
xp
os
ur
e,
 S
ou
th
 A
fr
ic
a,
 2
00
0
	
	
	
	
	
			
			
			
			
			
	M
al
e	
	
	
	
			
			
			
			
			
Fe
m
al
e	
	
	
	
			
			
			
			
	P
er
so
ns
O
ut
co
m
e	
	
	
	
		P
A
F	
(%
)	
			
			
			
			
D
ea
th
s	
			
			
			
			
			
			
			
		D
A
LY
s	
		P
A
F	
(%
)	
			
			
			
			
	D
ea
th
s	
			
			
			
			
			
			
			
D
A
LY
s	
	P
A
F	
(%
)	
			
			
			
			
		D
ea
th
s	
			
			
			
			
			
			
			
	D
A
LY
s
Is
ch
ae
m
ic
 h
ea
rt
 d
is
ea
se
 
 
   
   
   
 1
.7
  
   
   
   
   
   
 2
73
 
   
   
   
   
   
 2
 8
53
 
   
   
   
 1
.1
  
   
   
   
   
   
  1
49
 
   
   
   
   
   
1 
25
7 
   
   
   
1.
5 
   
   
   
   
   
   
42
2 
   
   
   
   
   
   
   
   
4 
11
0
St
ro
ke
 
 
 
 
   
   
   
 2
.5
  
   
   
   
   
   
 2
73
 
   
   
   
   
   
 3
 3
26
 
   
   
   
 1
.5
  
   
   
   
   
   
  2
48
 
   
   
   
   
   
2 
81
9 
   
   
   
1.
9 
   
   
   
   
   
   
52
1 
   
   
   
   
   
   
   
   
6 
14
5
H
yp
er
te
ns
iv
e 
d
is
ea
se
 
 
   
   
   
 4
.3
  
   
   
   
   
   
 2
03
 
   
   
   
   
   
 2
 0
86
 
   
   
   
 2
.7
  
   
   
   
   
   
  2
77
 
   
   
   
   
   
2 
37
8 
   
   
   
3.
2 
   
   
   
   
   
   
47
9 
   
   
   
   
   
   
   
   
4 
46
4
O
th
er
 c
ar
d
io
va
sc
ul
ar
 d
is
ea
se
s 
 
   
   
   
 2
.1
  
   
   
   
   
   
   
 3
 
   
   
   
   
   
   
 1
29
 
   
   
   
 1
.3
  
   
   
   
   
   
   
  2
 
   
   
   
   
   
   
10
5 
   
   
   
1.
7 
   
   
   
   
   
   
   
6 
   
   
   
   
   
   
   
   
   
 2
34
M
ild
 m
en
ta
l d
is
ab
ili
ty
 
 
   
   
10
0.
0 
   
   
   
   
   
   
  0
 
   
   
   
   
   
21
 6
08
 
   
   
10
0.
0 
   
   
   
   
   
   
   
0 
   
   
   
   
 2
2 
37
8 
   
  1
00
.0
 
   
   
   
   
   
   
   
0 
   
   
   
   
   
   
   
  4
3 
98
6
To
ta
l 
 
 
 
 
   
   
   
   
   
  7
52
 
   
   
   
   
   
30
 0
02
 
 
   
   
   
   
   
   
67
6 
   
   
   
   
 2
8 
93
7 
 
   
   
   
   
   
1 
42
8 
   
   
   
   
   
   
   
  5
8 
93
9
95
%
 u
nc
er
ta
in
ty
 in
te
rv
al
  
 
 
   
   
  5
77
 -
 9
28
   
   
 2
8 
02
2 
- 
31
 9
50
 
 
   
   
   
40
6 
- 
94
5 
 
26
 2
89
 -
 3
1 
52
6 
 
   
1 
08
6 
- 
1 
77
2 
   
   
   
 5
5 
41
3 
- 
62
 5
00
%
 o
f 
to
ta
l b
ur
de
n 
 
 
 
   
   
   
   
 0
.2
7%
 
   
   
   
   
   
 0
.3
5%
 
 
   
   
   
   
  0
.2
7%
 
   
   
   
   
   
0.
37
%
 
 
   
   
   
   
  0
.2
7%
 
   
   
   
   
   
0.
36
%
95
%
 u
nc
er
ta
in
ty
 in
te
rv
al
  
 
 
   
 0
.2
1 
- 
0.
34
%
   
   
   
   
   
 0
.3
3 
- 
0.
38
%
 
 
   
  0
.1
6 
- 
0.
38
%
   
   
   
   
  0
.3
4 
- 
0.
41
%
 
 
   
  0
.2
1 
- 
0.
34
%
   
   
   
   
   
0.
34
 -
 0
.3
9%
PA
F 
=
 p
op
ul
at
io
n-
at
tr
ib
ut
ab
le
 f
ra
ct
io
n;
 D
A
LY
s 
=
 d
is
ab
ili
ty
-a
d
ju
st
ed
 li
fe
 y
ea
rs
.
Attributable DALYs = 58 939
Persons
Mild mental disability in
children < 5 years
74.6%
Stroke
10.4%
Hypertensive disease
7.6%
Ischaemic heart disease
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to identify emerging risk factors for elevated blood lead 
concentrations in children as well as adults (especially with 
regard to ‘cottage industries’ and the use of lead in cultural/
traditional practices), significant scaling up of awareness 
programmes to address lack of knowledge of the sources and 
hazards of lead, and initiatives, in the context of a resource-
poor country such as South Africa, to address the problem 
of the estimated 25% of homes and schools that are currently 
coated with lead-based paint.  Testing needs to be carried out 
to identify high-risk buildings, and provision should be made 
for the safe management of lead-based paint in the worst-
affected dwellings and schools using a combination of in-place 
containment and more permanent removal methods.12
Given the associations between lead exposure and poor 
school performance as well as delinquent behaviour, it is 
extremely important for South Africa to set standards for 
children’s blood lead levels and to develop protocols to 
respond to children with elevated blood lead levels.
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